Showing all 3 results
Ondansetron Injection
FreeProduct Composition & Strength
We supply this product as a Sterile, Clear, Aqueous Solution in glass ampoules or vials.
Active Ingredient Concentration Total Content & Format Ondansetron (as HCl Dihydrate) 2 mg / ml 4 mg in 2 ml Glass Ampoule Ondansetron (as HCl Dihydrate) 2 mg / ml 8 mg in 4 ml Glass Ampoule Excipients Citric Acid / Sodium Citrate pH Buffer System (pH 3.3 to 4.0) *Pack Sizes: Tray of 5/10 Ampoules or Box of 50 Ampoules.
Ondansitron Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Engineered Flash-Dispersion ODT or Standard Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant peelable Alu-Alu blister strips to ensure the absolute chemical stability of the highly hygroscopic ODT matrix.
Active Ingredient Strength Primary Clinical Function Ondansetron (as HCl Dihydrate) Ph.Eur./USP 4 mg (ODT / FCT) Pediatric & PONV Standard: Base therapeutic unit for post-operative nausea, severe pediatric gastroenteritis, and mild emetic triggers. Ondansetron (as HCl Dihydrate) Ph.Eur./USP 8 mg (ODT / FCT) Global Oncology Standard: High-dose adult maintenance therapy for highly emetogenic chemotherapy (CINV) and radiation therapy (RINV). Excipients (ODT Formulation) Mannitol / Crospovidone / Aspartame / Colloidal Silicon Dioxide / Premium Mint Flavoring Lyophilized Matrix / Superdisintegrant / Sweetener / Saliva-Stimulating Flavor (Engineered specifically to draw saliva into the tablet matrix, forcing a violent, sub-5-second structural collapse on the tongue without a bitter aftertaste) *Pack Sizes: 10×10 Peelable Alu-Alu Blisters (Optimized specifically for strict oncology and surgical dispensing regimens).
